Michele Ilene Korfin - May 3, 2022 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Director
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Stock symbol
ORGO
Transactions as of
May 3, 2022
Transactions value $
$0
Form type
4
Date filed
5/5/2022, 05:21 PM
Previous filing
Feb 1, 2022
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Award $0 +23.9K $0.00 23.9K May 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on May 3, 2023.